scholarly journals Primary Hepatic Neuroendocrine Tumor with Unusual Thyroid Follicular-Like Morphologic Characteristics

2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Mohd Elmugtaba Ibrahim ◽  
Kerolos Abadeer ◽  
Qihui (Jim) Zhai ◽  
Aziza Nassar

We describe a primary hepatic neuroendocrine tumor of a 57-year-old Thai woman who presented in 2004 with a suspicious mass in the left hepatic lobe. She underwent left hepatectomy for the 10.5-cm mass, calledintermediate grade neuroendocrine carcinoma of unknown origin,likely metastatic. The tumor recurred in 2007, then calledrecurrent primary hepatic neuroendocrine tumor(PHNET), and the patient underwent liver transplant. Because of similarity between the neuroendocrine tumor and a thyroid tumor—specifically, follicular-like characteristics—immunohistochemical stains for thyroglobulin, TTF1, and calcitonin were performed. However, all were negative. All imaging studies revealed no evidence of a primary lesion other than the liver mass. In 2008, the patient’s liver transplant failed because of ischemic cholangiopathy, and she underwent a second liver transplant. Seven years later, in 2015, she presented with metastatic neuroendocrine tumor of intermediate grade to the lung, consistent with metastatic PHNET. She underwent left upper-lobe wedge resection to remove the tumor. The patient is alive with no evidence of disease at 13 years after initial diagnosis. This rare variant of PHNET had thyroid-like morphologic characteristics but there is no evidence of primary thyroid tumor or thyroid markers in the primary and recurrent hepatic tumors and lung metastasis.

1990 ◽  
Vol 12 (5) ◽  
pp. 533-537 ◽  
Author(s):  
Angel E. Alsina ◽  
Stanley Bartus ◽  
David Hull ◽  
Robert Rosson ◽  
Robert T. Schweizer

2021 ◽  
pp. 90-97
Author(s):  
Pak Chiu Wong ◽  
Wong Hoi She ◽  
Ui Soon Khoo ◽  
Tan To Cheung

We report an unusual presentation of primary hepatic neuroendocrine tumor which was initially misdiagnosed as intrahepatic cholangiocarcinoma. The diagnosis was only revealed after a major liver resection by histopathology. With adjuvant lanreotide injection, the patient survived for more than 16 months after the operation without tumor recurrence. Diagnosis of this rare tumor has been a major challenge and we emphasize the importance of a preoperative diagnosis. Surgical resection remains the mainstay for curative treatment, while peptide receptor radionuclide therapy is an emerging treatment option which has provided promising results.


2015 ◽  
Vol 15 (11) ◽  
pp. e1-e3
Author(s):  
Kanji Mori ◽  
Kazuya Nishizawa ◽  
Akira Nakamura ◽  
Mitsuaki Ishida ◽  
Shinji Imai

2003 ◽  
Vol 35 (2) ◽  
pp. 809-810 ◽  
Author(s):  
C Cahlin ◽  
S Friman ◽  
H Ahlman ◽  
L Backman ◽  
L Mjornstedt ◽  
...  

Author(s):  
Masaru SASAKI ◽  
Hiroyuki NAKABA ◽  
Hiroshi TAMAGAWA ◽  
Hiroyuki KIKKAWA ◽  
Eiji TANIGUCHI ◽  
...  

Author(s):  
Yusuke Koda ◽  
Yusuke Ome ◽  
Kenichi Saga ◽  
Kazuyuki Kawamoto

2019 ◽  
Vol 84 (3) ◽  
pp. 414-416
Author(s):  
M. Vilatobá ◽  
S. Hurtado-Gómez ◽  
I. García-Juárez ◽  
D. Huitzil-Melendez ◽  
A. Gamboa-Domínguez

Sign in / Sign up

Export Citation Format

Share Document